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Stromal effects
Previous reports provided compelling evidence that the chlo-
ride intracellular channel 4 (CLIC4) protein functions to promote 
human cancer stroma, which has a profound influence on 
tumor development and progression. In fact, one characteristic 
of such activated stroma is the conversion of fibroblasts to myo-
fibroblasts, which are crucial in supporting tumor progression 
and invasion. Shukla and colleagues recently demonstrated that 
fibroblast CLIC4 is important for this cell type conversion in the 
stroma. Transforming growth factor (TGF)-β drives this conversion 
via enhancement of matrix remodeling, growth factor secretion, 
production of antiapoptotic factors, and stimulation of cancer 
progression. CLIC4 is induced by TGF-β and thus contributes 
to cancer progression. Specifically, CLIC4 is involved in TGF-β-
dependent induction of cell migration, invasion, and the epithe-
lial–mesenchymal transition. Currently, inhibitors of TGF-β are 
being developed for cancer therapy; however, the broad func-
tions of this cytokine suggest potential difficulties with treatment 
application. Based on the results of this study, CLIC4 may provide 
a more specific target to limit the stromal reaction and effectively 
halt tumor growth. (Oncogene, published online 18 February 
2013; doi:10.1038/onc.2013.18) Selected by B. Gilchrest
Headed to the exits
Although bacterial pathogens such as Staphylococcus aureus pro-
duce peptide toxin phenol-soluble modulins (PSMs), which play 
key roles in pathogenesis and are thus likely excellent targets for 
drug development, targeting these molecules for therapeutic inter-
vention is hampered by their multitude and diversity. Chatterjee 
and colleagues recently discovered that PSMs are exported by an 
ATP-binding cassette transporter with two membrane parts (PmtB 
and PmtD) and two ATPases (PmtA and PmtC). Secretion of all 
S. aureus PSMs as well as growth of these bacteria was strongly 
dependent on Pmt. Expression of PSM peptides affected lysis of 
human neutrophils and erythrocytes and survival of S. aureus in 
human blood, suggesting that Pmt affects key virulence pheno-
types. Furthermore, Pmt was indispensable for the development of 
S. aureus skin infection in a mouse model. In sum, these results sug-
gest that a common PSM exporter offers a good drug target because 
this exporter facilitates secretion of an entire class of bacterial toxins 
and impacts virulence, microbial growth, and defense against bac-
terial interference. (Nat Med 19:364–7, 2013) Selected by L. Beck
Drive cancer into submission
Adaptive immunity is known to control human cancer. Cancer 
immunotherapy is used to arrest cancer growth or induce slow 
tumor regression, and these therapies correlate with tumor-
specific IFN-γ-producing CD4+ T-helper cells rather than 
cytotoxic T lymphocytes. In a recent study, Braumüller and 
colleagues found that adaptive TH1 immunity directly combats 
cancer proliferation through IFN-γ- and tumor necrosis factor 
(TNF)-mediated cancer cell senescence. These cytokines drive 
permanent growth arrest in G1/G0, activation of p16INK4a, and 
hypophosphorylation of retinoblastoma protein. Interestingly, 
these effects require STAT1 and TNF receptor (TNFR). In mice 
lacking TNFR (Tnfr1−/− mice), cancer cells resist cytokine-
induced senescence and grow aggressively. Taken together, these 
results indicate that combined IFN-γ and TNFR1 signaling drives 
cancers into senescence, and they provide insight into the direct 
mechanism of the antiproliferative effects of adaptive immunity 
on cancers. (Nature 464:361–5, 2013) Selected by T. Schwarz
Resolving the genetically unresolved
In an effort to identify causative mutations in patients with 
unexplained autosomal-recessive albinism (oculocutane-
ous albinism, OCA), Grønskov and colleagues employed 
homozygosity mapping of an inbred Faroese family. Subsequent 
sequence analysis of C10orf11, one of five protein-encoding 
genes contained within the identified 3.5-Mb homozygous 
region on chromosome 10, uncovered a homozygous nonsense 
mutation that segregated with OCA disease and displayed a 
recessive inheritance pattern. C10orf11 protein was expressed 
in melanoblasts and melanocytes in human fetal tissues. Turning 
to the model organism zebrafish, these investigators observed 
decreased pigmentation and reduction in pigmented melano-
cytes upon knockdown of the C10orf11 homolog. Rescue of 
these defects with wild-type C10orf11 confirmed a role for this 
protein in melanocyte differentiation and OCA via a pathway 
involving β-catenin/MITF signaling. (Am J Hum Genet 92:415–
21, 2012) Selected by J. Uitto
Immune tug of war
T helper type 1 cell responses and production of type II IFNs, such 
as IFN-γ, are critical for protective immunity against intracellular 
bacteria; however, induction of type I IFNs, which are important 
for host defense against viral pathogens, is ineffective for bacterial 
pathogens. Type I IFNs seemingly suppress IFN-γ-induced 
antimicrobial responses. To explore this situation in depth, Rosane 
and colleagues compared immune responses in self-healing 
tuberculoid form (T-lep) and the disseminated lepromatous 
form (L-lep) of leprosy caused by Mycobacterium leprae. Gene 
profiles revealed that IFN-β and IFN-γ gene expression profiles 
were inversely correlated. IFN-γ and the downstream vitamin D–
dependent antimicrobial genes were preferentially expressed in 
T-lep, whereas IFN-β and IL-10 were primarily induced in L-lep 
forms. Importantly, the IFN-γ-induced response was inhibited 
by IFN-β and IL-10, suggesting that differential production of 
IFNs determines whether protection or pathogenesis prevails. 
Moreover, these data aid our understanding of host resistance 
versus susceptibility, accentuating our ability to develop new 
approaches for prevention or treatment of infectious diseases. 
(Science 339:1448–53, 2012) Selected by L. GoldsmithJournal of Investigative Dermatology (2013) 133, 1701. doi:10.1038/jid.2013.211
